Is Shield Therapeutics PLC halal to invest in?

According to Musaffa's Shariah screening methodology, Shield Therapeutics PLC (STX.L) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Shield Therapeutics PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Shield Therapeutics PLC using these criteria to determine its compliance status.

Can Muslims buy shares of Shield Therapeutics PLC?

Muslim investors may consider investing in Shield Therapeutics PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Shield Therapeutics PLC classified as NOT HALAL?

Musaffa determines the Shariah status of Shield Therapeutics PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Shield Therapeutics PLC updated?

The Shariah compliance status of Shield Therapeutics PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Shield Therapeutics PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Shield Therapeutics PLC?

You can check the latest Shariah compliance status of Shield Therapeutics PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Shield Therapeutics PLC STX.L

GBX6.88 GBX0.05 (0.72%) 1D

Last Updated: May 15, 12:00 AM·LSE

STX.L Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: October 08, 2025

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for Shield Therapeutics PLC (STX.L)

Based on 11 analysts giving stock ratings to Shield Therapeutics PLC in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Shield Therapeutics PLC. Stock Analysis STX.L

United Kingdom Health Care Micro Cap Report: Q2, 2025

Shield Therapeutics Plc is a commercial stage specialty pharmaceutical company, which engages in addressing iron deficiency with its lead product Accrufer. The firm delivers differentiated specialty pharmaceuticals that address a significant unmet need for patients suffering from iron deficiency, with or without anemia. The Company’s lead product, Accrufer/Feraccru, is broadly indicated for use in adults across multiple therapeutic categories. Ferric maltol is approved in the United States, European Union, the United Kingdom, Canada, Australia and Switzerland for the treatment of iron deficiency with or without anemia in adults. The company also has an exclusive licence agreement with Beijing Aosaikang Pharmaceutical Co., Ltd., for the development and commercialization of ACCRUFeR/FeRACCRU in China, Hong Kong, Macau and Taiwan, with Korea Pharma Co., Ltd. for the Republic of Korea. The firm's subsidiaries include Phosphate Therapeutics Limited, Shield TX (Switzerland) AG, Shield Therapeutics Inc, and Shield TX (UK) Limited.

Key Statistics of Shield Therapeutics PLC (STX.L)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

GBX6.60GBX7.00

Today's Open

GBX6.93

Volume

1.06M

P/E Ratio (TTM)

52 Week Range

GBX2.20GBX12.50

Market Cap

8.44B

Avg. Volume

642.34K

Dividend Yield

Financial Metrics & Statements of Shield Therapeutics PLC (STX.L)

FAQ's for Shield Therapeutics PLC (STX.L)

According to Musaffa’s Shariah screening methodology, Shield Therapeutics PLC (STX.L) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.